My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Arch Neurol. 1991 Dec;48(12):1244-6.

    Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy.

    Ransohoff RM, Estes ML.

    Department of Molecular Biology, Research Institute, Cleveland Clinic Foundation, OH 44195-5178.

    Erratum in:

    • Arch Neurol 1992 Jul;49(7):752.

    Major histocompatibility complex (MHC) class I and class II antigens were characterized by immunocytochemistry in two chronic-active multiple sclerosis lesions in tissue obtained from two patients by stereotactic biopsy. We examined in particular astrocytic MHC-positive cells in relation to lesion architecture. The MHC class I (HLA-A,B,C)-positive astrocytic cells were widely dispersed, being present at the lesion edge, in the gliotic lesion center, and in normal-appearing white matter as well. Morphologically astrocytic MHC class II (HLA-DR)-positive cells were confined exclusively to the lesion edge. By staining serial sections with antisera to glial-fibrillary acidic protein and HLA-DR, we confirmed the lineage of several MHC class II-positive astrocytes. The demonstration of MHC antigen-positive astrocytes in multiple sclerosis tissue obtained by stereotactic biopsy is novel; the differential distribution of MHC class I- and class II-positive astrocytes in the multiple sclerosis lesion may provide suggestive clues about the regulation of MHC expression on these cells in vivo.

    PMID: 1845026 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read
    Write to the Help Desk